The body fights HIV alone: science investigates rare individuals in search of a new cure

Loreen Willenberg, a 71-year-old woman who lived in California, represented an enigma for decades to the scientific community in the fight against HIV. Diagnosed in 1992, she was one of the rare “elite controllers,” individuals capable of suppressing the virus in their bodies without the need for antiretroviral medication. His normal life, despite the infection, defied conventional understanding of the disease.
In a remarkable breakthrough announced at the 2025 International AIDS Society, researchers led by Professor Xu Yu of the Ragon Institute announced that Willenberg was likely completely free of HIV. This statement was made shortly before his death in April 2026 from cancer, but he left an irrefutable legacy: proof that the human body can, in exceptional circumstances, eradicate one of the most challenging viruses in history.
Uncovering natural resistance to HIV
The term “elite controllers” describes a small fraction, about 0.5%, of all HIV-infected people who manage to keep the virus under control. Unlike most, their bodies do not develop AIDS and do not need antiretroviral treatments to contain viral replication. For many years, this ability has intrigued the scientific community.
Willenberg’s quirkiness became even more evident when, in 2022, she was diagnosed with stage four cancer. Intense HIV therapies, which typically suppress the immune system, should have allowed HIV to reemerge. However, the virus remained undetectable, confirming its extraordinary resistance.
Nature’s tactic: viral entrapment in “genetic deserts”
Normally, HIV replicates by inserting its genetic material into the DNA of the host’s cells, spreading quickly and attacking white blood cells. Antiretroviral drugs, developed in the mid-1990s, were crucial in preventing viral replication and the disease’s progression to AIDS, allowing millions of people to live with the infection.
However, these medications generally do not completely eliminate the virus, which remains latent in “reservoirs” in the body. In elite controllers, like Loreen and the patient Esperanza from Argentina, the situation is different. 2020 research conducted by Xu Yu and his team on 64 such individuals revealed a surprising mechanism:
- Genetic lock-in:The virus is confined to vast regions of DNA known as “genetic deserts.”
- Inability to replicate:In these areas, HIV is isolated from active genes, prevented from hijacking the genetic machinery necessary to multiply.
- Functional healing:This phenomenon suggests a “functional cure” model, where the virus is present but inactive and harmless.
CD8+ T cells, an arm of these controllers’ adaptive immune systems, are believed to be specially equipped to force HIV to take refuge in these genetically inert regions.
The innate army: natural killer cells on the front lines
In addition to CD8+ T cells, recent studies point to the fundamental role of natural killer (NK) cells, part of the innate immune system, which is the body’s first line of defense. In a group of French patients, the Visconti cohort, who managed to live without antiretrovirals after years of treatment, genetic variants were found that influence the behavior of NK cells.
Christina Thobakgale, head of the immunology division at the University of the Witwatersrand, led research that showed that elite controllers have more NK cells expressing the CD69 molecule, an activation biomarker. These highly active cells appear to be capable of detecting and destroying cells infected by the virus, including in deep locations in the body, such as the intestines and lymph nodes.
The hypothesis is that efficient NK cells can help eliminate “hidden foci” of HIV. If this theory is proven, it could guide the development of therapeutic vaccines that activate NK cells in these strategic locations, mimicking the biology of elite controllers and overcoming one of the biggest challenges in curing HIV: the virus’s ability to hide.
Why women are crucial in the search for an HIV cure
A significant fact, and often overlooked in research, is that the majority of elite controllers are women. New investigations indicate that the female innate immune system may have NK cells that are more effective in combating HIV. Despite this, historically, most clinical trials focused on eradicating the virus have been carried out in men.
Professor Xu Yu highlights this disparity: “We don’t study enough women in trials and studies related to healing,” she says. She points out that women are two to five times more likely to become elite controllers, which highlights the urgent need to target more research at this population. Better understanding female immunological characteristics could significantly accelerate the development of new therapies and vaccines.
The legacy of a life and the hope of eradication
The story of Loreen Willenberg and other elite controllers is a beacon of hope for the 40.8 million people living with HIV globally. Their experiments offer valuable insights into the human body’s ability to resist and, in rare cases, eradicate the virus on its own.
Advances in understanding “genetic deserts” and the role of NK cells open new avenues for developing next-generation treatments. The inclusion and focus on female biology in studies can unlock even more secrets. Although Loreen did not live to see the end of the epidemic, her contributions pave the way for a future where an HIV cure can become a reality for everyone.






